BongQuixote
Rising Star
I agree. There is still a business model that makes sense, which I think would follow the weed model once compounds get legalized. Small outlets, maybe prescription only at first, warning labels, strict government quality control and safety checks, analysis of substance content and strength. No patents you need to license, just regular growers or labs doing their thing and selling directly through retail stores after inspection. This would allow mental health professional use in their practices and "self medication" for anyone interested. I've seen how the market changed in Seattle after the weed legalization and it's now:bismillah said:BongQuixote said:I don't see any big established pharma companies interested in providing psychedelic drugs to the public. Since the molecules and techniques are already known and in the public domain, there is no money to be made through copyrights, which is how drug companies make money. I don't think generic manufacturing of a niche product with a small market is the business they want to be in. Same with weed, that's why the drug companies are not all over it. There is no money to be made.bismillah said:tango said:How about the financial aspect, do you guys think it's a good investment at this point? I just did a search for psychedelic medicine companies, and was surprised to see how many there are, considering the legal status of psychedelics.
Personally I think it's a fine time if you have some money you're willing to put away for a long while. Stocks are coming out of an initial hype phase and seem a bit overvalued at the moment. That said, I don't see any way to go but up in the long run.
Yes, you are right, but "no money" is an overstatement. There is still very good potential for profit, I believe, ignoring the question of the morality of it. I also think big pharma companies would not want to compete with their own synthetic antidepressants and anxiolytics, contributing to their avoidance of psychedelics (hey, isn't that one theory as to why they were demonized in the first place?).
But just because Pfizer isn't about to start growing shrooms doesn't mean it's unprofitable. There are plenty of manufacturing methods to be patented, and research to be done, and expensive therapies to be devised, and liberal corporations to be charged for employee counselling![]()
1. Cheaper
2. Higher quality, guaranteed by the government to be free of pesticides and additives
3. Better selection, not only with strains but with type of products
4. No longer a social stigma
So I'm all for it. Legalize, tax and make it a safe market.